🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Leukocyte Disorders

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages NCT02523118n/a19 sites📍 Phoenix📍 Rogers📍 San Diego Children's Hospital Medical Center, Cincinnati The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome NCT07275190NA1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia · Tests: Blood draw for the laboratory assessment Investigation of the Genetics of Hematologic Diseases NCT02720679n/a1 site📍 Memphis St. Jude Children's Research Hospital Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders NCT00267501n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati Natural History of Eosinophilic Esophagitis in Adult and Pediatric Population NCT07614633n/a2 sites📍 Pavia📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing Eosinophils NCT04538937n/a1 site📍 Innsbruck Medical University Innsbruck · Tests: no intervention Collection of Lung Fluid and Tissue Samples for Research NCT00471250n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia NCT00001406n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Myeloproliferative Neoplasms (MPNs) Patient Registry NCT02760238n/a1 site📍 Toronto University Health Network, Toronto · Tests: Observational European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank NCT02852928n/a3 sites📍 Hanover📍 Ankara📍 Edinburgh Matthias Griese Physiology and Pathologies Linked to Human Splenic Function : Direct and Ex-vivo Perfusion Explorations NCT06418256n/a5 sites📍 Clichy📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Spleen, blood and plasma collection Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site📍 Pittsburgh Paul Szabolcs · Tests: data collection Natural History and Genetics of Food Allergy and Related Conditions NCT02504853n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… A Study of Depemokimab in Participants of 6 to 11 Years of Age NCT07671001Phase 33 sites📍 Mobile📍 Colorado Springs📍 Watertown GlaxoSmithKline · Tests: Depemokimab Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD NCT03055247Phase 22 sites📍 Rome📍 Milan IRCCS San Raffaele · Tests: Ibuprofen, Myelostim, Mozobil A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy NCT07214753n/a28 sites📍 Salerno📍 Padova📍 Teramo AstraZeneca · Tests: benralizumab A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE). NCT05608681Phase 1, Phase 223 sites📍 Sydney📍 Brisbane📍 Brisbane Eupraxia Pharmaceuticals Inc. · Tests: EP-104GI, Matching vehicle control Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation NCT06809699Phase 11 site📍 Hangzhou He Huang · Tests: Busulfan (Busulfex), Cyclophosphamide (CTX), Fludarabine (Fludara), Semustine (MeCCNU) Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists NCT05463133Phase 1, Phase 21 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Sirolimus, Cyclophosphamide, Alemtuzumab, Busulfan, Pheripheral blood stem cells Serial Blood Count Study NCT07066085EARLY Phase 11 site📍 Seattle University of Washington · Tests: Serial Blood Count Study, Athelas Home device Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection NCT07434063n/a1 site📍 Shijiazhuang Hebei Medical University Fourth Hospital · Tests: Mecapegfilgrastim Injection Prevalence and Description of FIRE (Food Induced Immediate Response of the Esophagus) in the Pediatric Population With Eosinophilic Esophagitis NCT06972147n/a2 sites📍 Angers📍 Lille University Hospital, Angers Prospective Registry of EoSinophilic esOphagitis NCT06443346n/a1 site📍 Milan IRCCS San Raffaele · Tests: Eosinophilic Esophagitis Prospective Study of White Blood Cells NCT04838171n/a1 site📍 London Quell Therapeutics Limited · Tests: White blood cell and blood collection A Non-interventional, Prospective Study With Benralizumab NCT06422078n/a41 sites📍 Ahrensburg📍 Ansbach📍 Aschaffenburg AstraZeneca Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors NCT06584006Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Thymalfasin for injection in combination with Recombinant Human Interleukin-2 Injections, Recombinant Human Interleukin… Predictive Signature of Benralizumab Response NCT04565483Phase 420 sites📍 Aix-en-Provence📍 Angers📍 Bordeaux Nantes University Hospital · Tests: Benralizumab Prefilled Syringe Biologicals in Management of Intra-Bony Defects NCT07292870NA1 site📍 Leuven Universitaire Ziekenhuizen KU Leuven · Tests: Minimally invasive surgical treatment of the intra-bony defects, Use of the xenograft Bio-Oss® Collagen during the surg… Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia NCT02115295Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cladribine, Cytarabine, Gilteritinib, Idarubicin, Laboratory Biomarker Analysis Genetic Studies of Chronic Active Epstein-Barr Disease NCT00032513n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy